Tag Archives: Raju Prasad
William Blair Downgrades Loxo Oncology (LOXO) to Hold
In a report released today, Raju Prasad from William Blair downgraded Loxo Oncology (LOXO – Research Report) to Hold. The company’s shares opened today at $233.31, close to its 52-week high of $233.90. According to TipRanks.com, Prasad is a 4-star
PTC Therapeutics (PTCT) Gets a Buy Rating from William Blair
In a report released today, Raju Prasad from William Blair maintained a Buy rating on PTC Therapeutics (PTCT – Research Report). The company’s shares opened today at $35.67. According to TipRanks.com, Prasad is a 1-star analyst with an average return
William Blair Maintains a Buy Rating on Loxo Oncology (LOXO)
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Loxo Oncology (LOXO – Research Report). The company’s shares closed on Friday at $139.87. According to TipRanks.com, Prasad is a 1-star analyst with an average
Bluebird Bio (BLUE) Gets a Buy Rating from William Blair
William Blair analyst Raju Prasad maintained a Buy rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares opened today at $116.86, close to its 52-week low of $102.21. According to TipRanks.com, Prasad is a 2-star analyst with
William Blair Thinks Spark Therapeutics’ Stock is Going to Recover
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Spark Therapeutics (ONCE – Research Report). The company’s shares closed on Friday at $42.13, close to its 52-week low of $35.63. According to TipRanks.com, Prasad
Rocket Pharmaceuticals Inc (RCKT) Gets a Buy Rating from William Blair
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Rocket Pharmaceuticals Inc (RCKT – Research Report). The company’s shares closed yesterday at $16.16. According to TipRanks.com, Prasad is a 1-star analyst with an average
